WLF: leave ethics out of approvals

Calls by bioethicists and environmentalists for the FDA to consider other decidedly unscientific factors, including ethics and healthcare costs, when deciding a product approval decision are “absurd,” according to two senior officers of the American Council on Science and Health writing in a Washington Legal Foundation legal opinion letter. They were responding to an earlier article appearing in the Baltimore Sun.
They claim there are already “too many non-science factors working on FDA drug professionals. ... The intrusion of ‘ethics' into the drug evaluation process would lead to increased regulation of the drug industry, probably to the point of regulating it out of existence.”
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.